Vyome Holdings, Inc. Share Price
NASDAQ: HIND | Micro CapVyome Holdings, Inc. Stock Performance
Vyome Holdings, Inc. Share Price Chart
Vyome Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Vyome Holdings, Inc. Annual Profit & Loss
All figures in USD
About Vyome Holdings, Inc.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Vyome Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.92 | $1.76 | -7.85% |
Sep 2026 | $2.17 | $1.91 | -15.49% |
Aug 2026 | $2.18 | $2.26 | +7.62% |
Jul 2026 | $2.24 | $2.10 | -5.41% |
Jun 2026 | $2.33 | $2.22 | -6.33% |
May 2026 | $2.07 | $2.37 | +8.72% |
Apr 2026 | $2.26 | $2.18 | +2.83% |
Mar 2026 | $3.33 | $2.12 | -37.28% |
Feb 2026 | $1.89 | $3.38 | +78.36% |
Jan 2026 | $3.49 | $1.90 | -44.91% |
Dec 2025 | $5.13 | $3.44 | -23.73% |
Nov 2025 | $6.30 | $4.51 | -24.33% |